Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 73

1.

Colorectal cancer in a patient with intestinal schistosomiasis: a case report from Kilimanjaro Christian Medical Center Northern Zone Tanzania.

Herman AM, Kishe A, Babu H, Shilanaiman H, Tarmohamed M, Lodhia J, Amsi P, Pyuza J, Mremi A, Mwasamwaja A, Nyindo M, Chilonga K, Msuya D.

World J Surg Oncol. 2017 Aug 2;15(1):146. doi: 10.1186/s12957-017-1217-1.

2.

Evasin-displaying lactic acid bacteria bind different chemokines and neutralize CXCL8 production in Caco-2 cells.

Škrlec K, Pucer Janež A, Rogelj B, Štrukelj B, Berlec A.

Microb Biotechnol. 2017 Nov;10(6):1732-1743. doi: 10.1111/1751-7915.12781. Epub 2017 Jul 24.

3.

Fluorescein as a topical fluorescent contrast agent for quantitative microendoscopic inspection of colorectal epithelium.

Prieto SP, Lai KK, Laryea JA, Mizell JS, Mustain WC, Muldoon TJ.

Biomed Opt Express. 2017 Mar 24;8(4):2324-2338. doi: 10.1364/BOE.8.002324. eCollection 2017 Apr 1.

4.

MDR1A deficiency restrains tumor growth in murine colitis-associated carcinogenesis.

Hennenberg EM, Eyking A, Reis H, Cario E.

PLoS One. 2017 Jul 7;12(7):e0180834. doi: 10.1371/journal.pone.0180834. eCollection 2017.

5.

Hypotheses on the Potential of Rice Bran Intake to Prevent Gastrointestinal Cancer through the Modulation of Oxidative Stress.

Law BMH, Waye MMY, So WKW, Chair SY.

Int J Mol Sci. 2017 Jun 24;18(7). pii: E1352. doi: 10.3390/ijms18071352. Review.

6.

Innate Lymphoid Cells in Tumor Immunity.

van Beek JJP, Martens AWJ, Bakdash G, de Vries IJM.

Biomedicines. 2016 Feb 25;4(1). pii: E7. doi: 10.3390/biomedicines4010007. Review.

7.

The neuroprotective effects of human bone marrow mesenchymal stem cells are dose-dependent in TNBS colitis.

Robinson AM, Rahman AA, Miller S, Stavely R, Sakkal S, Nurgali K.

Stem Cell Res Ther. 2017 Apr 18;8(1):87. doi: 10.1186/s13287-017-0540-3.

8.

A potential anti-tumor effect of leukotriene C4 through the induction of 15-hydroxyprostaglandin dehydrogenase expression in colon cancer cells.

Mehdawi LM, Satapathy SR, Gustafsson A, Lundholm K, Alvarado-Kristensson M, Sjölander A.

Oncotarget. 2017 May 23;8(21):35033-35047. doi: 10.18632/oncotarget.16591.

9.

Thymoquinone potentiates chemoprotective effect of Vitamin D3 against colon cancer: a pre-clinical finding.

Mohamed AM, Refaat BA, El-Shemi AG, Kensara OA, Ahmad J, Idris S.

Am J Transl Res. 2017 Feb 15;9(2):774-790. eCollection 2017.

10.

Applications of Genetically Modified Immunobiotics with High Immunoregulatory Capacity for Treatment of Inflammatory Bowel Diseases.

Shigemori S, Shimosato T.

Front Immunol. 2017 Jan 25;8:22. doi: 10.3389/fimmu.2017.00022. eCollection 2017. Review.

11.

Increased Levels of Circulating and Tumor-Infiltrating Granulocytic Myeloid Cells in Colorectal Cancer Patients.

Toor SM, Syed Khaja AS, El Salhat H, Bekdache O, Kanbar J, Jaloudi M, Elkord E.

Front Immunol. 2016 Dec 8;7:560. doi: 10.3389/fimmu.2016.00560. eCollection 2016.

12.

Risk factors for developing colorectal cancer in Japanese patients with ulcerative colitis: a retrospective observational study-CAPITAL (Cohort and Practice for IBD total management in Kyoto-Shiga Links) study I.

Yoshino T, Nakase H, Takagi T, Bamba S, Okuyama Y, Kawamura T, Oki T, Obata H, Kawanami C, Katsushima S, Kusaka T, Tsujikawa T, Naito Y, Andoh A, Kogawa T.

BMJ Open Gastroenterol. 2016 Nov 24;3(1):e000122. eCollection 2016.

13.

A microfluidic chip based model for the study of full thickness human intestinal tissue using dual flow.

Dawson A, Dyer C, Macfie J, Davies J, Karsai L, Greenman J, Jacobsen M.

Biomicrofluidics. 2016 Nov 1;10(6):064101. eCollection 2016 Nov.

14.

A novel variant on chromosome 6p21.1 is associated with the risk of developing colorectal cancer: a two-stage case-control study in Han Chinese.

Xu C, Zhou D, Pan F, Liu Y, Zhang D, Lin A, Miao X, Ni Y, Lv D, Zhang S, Li X, Zhu Y, Lai M.

BMC Cancer. 2016 Oct 18;16(1):807.

15.
16.

Colorectal Cancer and Dysplasia in Inflammatory Bowel Disease: A Review of Disease Epidemiology, Pathophysiology, and Management.

Dulai PS, Sandborn WJ, Gupta S.

Cancer Prev Res (Phila). 2016 Dec;9(12):887-894. Epub 2016 Sep 27. Review.

PMID:
27679553
17.

Research progress on chemopreventive effects of phytochemicals on colorectal cancer and their mechanisms.

Yin TF, Wang M, Qing Y, Lin YM, Wu D.

World J Gastroenterol. 2016 Aug 21;22(31):7058-68. doi: 10.3748/wjg.v22.i31.7058. Review.

18.

Expression Profile of p53 and p21 in Large Bowel Mucosa as Biomarkers of Inflammatory-Related Carcinogenesis in Ulcerative Colitis.

Popp C, Nichita L, Voiosu T, Bastian A, Cioplea M, Micu G, Pop G, Sticlaru L, Bengus A, Voiosu A, Mateescu RB.

Dis Markers. 2016;2016:3625279. doi: 10.1155/2016/3625279. Epub 2016 Aug 7.

19.

Characterization of TCP-1 probes for molecular imaging of colon cancer.

Liu Z, Gray BD, Barber C, Bernas M, Cai M, Furenlid LR, Rouse A, Patel C, Banerjee B, Liang R, Gmitro AF, Witte MH, Pak KY, Woolfenden JM.

J Control Release. 2016 Oct 10;239:223-30. doi: 10.1016/j.jconrel.2016.08.033. Epub 2016 Aug 26.

20.

Improving Clinical Remission Rates in Pediatric Inflammatory Bowel Disease with Previsit Planning.

Savarino JR, Kaplan JL, Winter HS, Moran CJ, Israel EJ.

BMJ Qual Improv Rep. 2016 Jul 29;5(1). pii: u211063.w4361. doi: 10.1136/bmjquality.u211063.w4361. eCollection 2016.

Supplemental Content

Support Center